Wei Li
Impact in
- Aging top 1%
- Molecular Biology top 1%
- CRISPR and Genetic Engineering
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Pluripotent Stem Cells Research
- Cancer-related gene regulation
Papers in
-
- CRISPR and Genetic Engineering 45
- Pluripotent Stem Cells Research 40
- RNA Research and Splicing 20
- RNA modifications and cancer 18
- Epigenetics and DNA Methylation 15
- Genetics 55
- Virus-based gene therapy research 27
- Mesenchymal stem cell research 14
- Co-authors
- Qi Zhou (55 shared papers)Guihai Feng (28 shared papers)Kai Xu (12 shared papers)Lu Guo (8 shared papers)Kevin R. Francis (1 shared paper)Yuhuan Li (6 shared papers)Tongtong Cui (12 shared papers)Qingqin Gao (6 shared papers)
- Journals
- Cell Proliferation (13 papers)Cell Death and Disease (7 papers)Nature Communications (6 papers)Protein & Cell (5 papers)Biochemical and Biophysical Research Communications (5 papers)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Wei Li
321 papers receiving 10.4k citations
Wei Li's Hit Papers
Peers
Comparison fields: 5 of 188
- Aging 249
- Molecular Biology 5.2k
- Cancer Research 866
- Infectious Diseases 924
- Genetics 518
Countries citing papers authored by Wei Li
This map shows the geographic impact of Wei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Li more than expected).
Fields of papers citing papers by Wei Li
This network shows the impact of papers produced by Wei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Li. The network helps show where Wei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 342 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Risk factors for severe and critically ill COVID‐19 patients: A review Hit paper breakdown → | 2020 | 864 |
| 2 | 2020 | 415 | |
| 3 | Programming and Inheritance of Parental DNA Methylomes in Mammals Hit paper breakdown → | 2014 | 396 |
| 4 | 2017 | 339 | |
| 5 | 2009 | 310 | |
| 6 | CDetection: CRISPR-Cas12b-based DNA detection with sub-attomolar sensitivity and single-base specificity Hit paper breakdown → | 2019 | 292 |
| 7 | MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer Hit paper breakdown → | 2018 | 267 |
| 8 | 2020 | 244 | |
| 9 | 2018 | 231 | |
| 10 | 2018 | 228 | |
| 11 | 1998 | 222 | |
| 12 | 2015 | 217 | |
| 13 | 2014 | 131 | |
| 14 | 2010 | 126 | |
| 15 | 2018 | 126 | |
| 16 | 2021 | 126 | |
| 17 | 2002 | 123 | |
| 18 | 2011 | 120 | |
| 19 | 2011 | 115 | |
| 20 | 2022 | 111 |
About Wei Li
Wei Li is a scholar working on Molecular Biology, Genetics, Genetics, Pulmonary and Respiratory Medicine and Oncology, having authored 342 papers that have together received 10.5k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (45 papers), Pluripotent Stem Cells Research (40 papers), Virus-based gene therapy research (27 papers), RNA Research and Splicing (20 papers), RNA modifications and cancer (18 papers), Epigenetics and DNA Methylation (15 papers), CAR-T cell therapy research (15 papers) and Mesenchymal stem cell research (14 papers). The work is most often cited by research in Aging (249 citations), Molecular Biology (5.2k citations), Cancer Research (866 citations), Infectious Diseases (924 citations) and Genetics (518 citations). Wei Li has collaborated with scholars based in China, United States and India. Frequent co-authors include Qi Zhou, Guihai Feng, Kai Xu, Lu Guo, Kevin R. Francis, Yuhuan Li, Tongtong Cui, Qingqin Gao, Ying Yang and Botao Zhao. Their work appears in journals such as Cell Proliferation, Cell Death and Disease, Nature Communications, Protein & Cell and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.